Advisors Capital Management LLC Acquires 1,735 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Advisors Capital Management LLC boosted its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 1.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 170,776 shares of the company’s stock after acquiring an additional 1,735 shares during the period. Advisors Capital Management LLC owned 0.06% of Stevanato Group worth $3,721,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Van Berkom & Associates Inc. acquired a new stake in shares of Stevanato Group during the fourth quarter worth $39,000. Wells Fargo & Company MN grew its position in shares of Stevanato Group by 680.3% during the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock worth $71,000 after buying an additional 2,830 shares during the period. PNC Financial Services Group Inc. grew its position in shares of Stevanato Group by 1,457.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock worth $123,000 after buying an additional 5,291 shares during the period. US Bancorp DE increased its stake in shares of Stevanato Group by 17.9% in the 4th quarter. US Bancorp DE now owns 8,527 shares of the company’s stock valued at $186,000 after acquiring an additional 1,295 shares during the last quarter. Finally, Marco Investment Management LLC acquired a new stake in shares of Stevanato Group in the 4th quarter valued at approximately $203,000.

Analyst Upgrades and Downgrades

STVN has been the subject of several recent analyst reports. UBS Group lowered their target price on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday, March 7th. William Blair reissued an “outperform” rating on shares of Stevanato Group in a report on Friday, March 7th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of €25.70 ($29.20).

Stevanato Group Stock Up 5.8 %

STVN stock opened at €21.83 ($24.81) on Monday. Stevanato Group S.p.A. has a 1-year low of €16.56 ($18.82) and a 1-year high of €29.81 ($33.88). The business’s 50 day simple moving average is €20.50 and its 200 day simple moving average is €20.63. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $6.61 billion, a PE ratio of 46.45, a PEG ratio of 7.18 and a beta of 0.52.

Stevanato Group (NYSE:STVN) last announced its earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) earnings per share for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.23). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. As a group, research analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.